Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines
Introduction: In Argentina, a pentavalent whole-cell pertussis vaccine (wP) is used in the National Immunization Program, however hexavalent acellular pertussis (aP) vaccines are available in the private market. Objective: To describe parent or guardianś perceptions on reactogenicity, daily routine...
Main Authors: | Angela Gentile, Vanesa Edelvais Castellano, Anabella Pacchiotti, Mariela del Pino, Lucía Romero Bollón, Micaela Lieste, Mercedes Deluca, Juan C. Vargas-Zambrano |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Vaccine: X |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136223000803 |
Similar Items
-
Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
by: Kevin Markey, et al.
Published: (2019-07-01) -
Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
by: Aapo Knuutila, et al.
Published: (2023-12-01) -
Comparative analysis of whole-cell and acellular pertussis vaccines efficacy in preventing pertussis
by: I. A. Alekseeva, et al.
Published: (2018-02-01) -
Acellular Pertussis Vaccine Components: Today and Tomorrow
by: Kalyan K. Dewan, et al.
Published: (2020-05-01) -
Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis
by: E. M. Zaitsev, et al.
Published: (2017-04-01)